July 19, 2011

A relatively new class of drugs controlling blood levels of " good cholesterol "It turned out to demonstrate positive results diabetes type 2 Than statin .

Scientists in Australia have found that torcetrapib Belonging to this class of drugs, besides adjusting the content of cholesterol stabilizes blood sugar and reduces the risk of diseases of the cardiovascular system. In addition, significantly reduced instances of such consequences as the heart attack   and stroke .

It should be noted that   clinical trials this drug was discontinued in 2006. The reason for this was the fact that the use of drugs that control cholesterol levels, led to an increase in cases of heart attacks and deaths.

But scientists claim that not all the drugs in this group are so dangerous. For example, daltsetrapib   and anacetrapib   This security plan of his "brother" torcetrapib and have already been active research. Scientists have yet to find out whether these drugs are the same properties as the torcetrapib .

We recall that the employees were engaged in the study of torcetrapib Research Institute in Sydney (Australia). The study involved more than 6000 volunteers who have been diagnosed diabetes   the second type. Most of the subjects suffered from cardiovascular disease, had a heart attack and stroke.

All participants were divided into 2 groups. Members of one group were treated with torcetrapib, others took statin . As a result, the group that took torcetrapib, had lower blood sugar levels, but at the same time in this group was also observed large mortality   and increased cardiovascular system. Because of that, the experiment was terminated.